clostridium difficile
Researches suggest that Lachnospiraceae and Enterococcaceae, as well as bacterial metabolites such as propionate can contribute to radioprotection.
Researchers have engineered yeast to produce and deliver antibodies that neutralize the two bacterial toxins that cause tissue damage.
The largest study of fecal microbiota transplant in the UK shows that the procedure can successfully treat patients with C. diff infection.
